Top Boston, MA Biotech Companies With Best Work-Life Balance (307)
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform...
SOPHiA GENETICS's Top Work-Life Balance & Wellbeing Strengths
Remote or Hybrid Flexibility: Employer materials describe a remote program, flexible schedules, and hybrid setups combining office and WFH time. Feedback suggests eligible roles (including some field positions) can be arranged with non‑traditional hours or locations.
Time Off Access: Competitive PTO with holidays and sick time is highlighted, supporting time away when workloads allow. Feedback suggests formal allowances can help offset busy periods.
Meaningful Work: The mission in healthcare and impact on patients are frequently highlighted, with colleagues described as wonderful and the experience rewarding for growth. Feedback suggests purpose and team camaraderie help some employees sustain balance during demanding phases.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This...
Click Therapeutics's Top Work-Life Balance & Wellbeing Strengths
Remote or Hybrid Flexibility: Company profiles describe a hybrid model and a remote‑work program with flexible schedules that, when consistently applied by teams, support day‑to‑day balance.
Time Off Access: “Unlimited”/flexible PTO with paid sick days and company holidays is positioned to enable rest without strict accrual tracking.
Wellbeing Programs: Wellness funds, mental‑health groups, backup childcare/eldercare, One Medical membership, and fitness stipends reflect intentional investment in employee wellbeing.
Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the...
Benchling's Top Work-Life Balance & Wellbeing Strengths
Time Off Access: Unlimited PTO, paid sick time, paid holidays, parental leave, and a company-wide winter shutdown are emphasized, enabling real disconnection. Sabbaticals at five and ten years further signal institutional support for extended time away.
Remote or Hybrid Flexibility: A structured hybrid policy with set in-office days provides predictability while still preserving some remote flexibility for many roles. Flexible schedules are listed, helping employees plan around personal commitments.
Wellbeing Programs: Dedicated mental-health benefits, a monthly wellness stipend, employee resource groups, and an intentional winter break are highlighted as supports for wellbeing. These programs are positioned to encourage recharge.
We bring together one of the world’s largest libraries of multimodal clinical and molecular data with a robust suite of AI tools to help physicians personalize care in real time, connect patients with therapies and clinical trials, and enable partners to accelerate discovery and development of new treatments. With ~8 million de-identified research records and 350+ petabytes of data, Tempus partners...
Tempus AI's Top Work-Life Balance & Wellbeing Strengths
Remote or Hybrid Flexibility: Feedback suggests hybrid and remote options are available, with flexible scheduling on eligible teams. Some functions are fully remote while others are onsite-only, indicating structural flexibility where team norms align.
Boundary Respect: Feedback suggests certain teams maintain clear off-hours boundaries with no late nights or weekend work when not on call. This indicates that day-to-day expectations can support personal time where local norms are strong.
Meaningful Work: Feedback points to mission-driven, patient-impactful work in oncology and precision medicine as energizing and satisfying. This sense of purpose can help offset periods of higher intensity for some individuals.
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Work-Life Balance & Wellbeing Strengths
Recovery Time: Company benefits include over a month of paid vacation and company‑wide shutdown weeks, creating structured downtime for rest and recharge. Paid parental leave and other leaves further reinforce time away from work.
Remote or Hybrid Flexibility: Feedback suggests hybrid schedules and remote work programs let employees manage location and hours more autonomously. Flexibility around in‑office days and scheduling is highlighted as part of the work environment.
Work-Life Reputation: Balance is often characterized as good, with an easy‑going culture cited across locations. Feedback suggests this is a recognized strength of the company.
Obsidian Therapeutics is pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s programs apply our cytoDriveTM technology in cell and gene therapy products to control expression of proteins for enhanced therapeutic efficacy, including our lead program cytoTIL15 engineered to make TILs more effective for more patients. Our aspirations are high, and we’re built...
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. We leverage our world-class delivery systems and related technologies to bring new medicines to patients who need them. We do this by selectively collaborating with leading pharma and biotech...
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes across oncology, neurology and cardiology. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years.
We work at the frontier of programmable medicines. We power our bioplatform and product candidates by harnessing evolution and AI. We operate with purpose and urgency on behalf of people everywhere. We aim to generate life-changing impact for the world
Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance...
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a unique triple-action design currently being studied in atopic diseases. Poplar is pursuing the bold idea that IgE can be rapidly driven toward zero, with the goal of helping...
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation. eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing both the key virology...
Pillar Biosciences was founded in 2014, on the principle that in order for personalized medicine to be realized, clinical Next Generation Sequencing (NGS) workflows need to be affordable, rapid, robust, and flexible. We’re focused on productive solutions that enable streamlined workflows, so that labs can generate dependable results with less inputs, less labor, and less time. Our team makes precision...
Endpoint is an interactive response technology (IRT®) systems and solutions provider that supports the life sciences industry. Since 2009, we have been working with a single vision in mind, to help sponsors and pharmaceutical companies achieve clinical trial success. Our solutions, realized through the proprietary PULSE® platform, have proven to maximize the supply chain, minimize operational costs, and ensure timely...
Endpoint Clinical, Inc.'s Top Work-Life Balance & Wellbeing Strengths
Remote or Hybrid Flexibility: Feedback suggests remote and hybrid options help employees manage personal needs alongside work. Location flexibility appears to ease day-to-day demands for many roles.
Time Off Access: Feedback suggests unlimited PTO and generous leave policies enable recovery when workloads peak. These provisions are cited as improving balance compared to prior practices.
Mental Health Support: Feedback suggests the culture emphasizes mental health awareness and supportive resources. This focus helps buffer stress during demanding periods.
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio...
Dragonfly Therapeutics is a clinical-stage biotech developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. Our molecules are expected to be potent as single agents as well as in treatment combinations with existing...
At Ark, we are transforming bioprocessing by championing a model-first approach that combines biology, chemistry, and physics with the predictive power of machine learning and AI. By replacing traditional trial-and-error methods with hybrid models, we empower organizations to predict outcomes, optimize processes, and scale with precision—dramatically reducing R&D timelines, cutting costs, and increasing accessibility to life-saving therapies and innovative products....
Landmark Bio is a collective endeavor launched by leaders from academia, the life sciences industry, and world-renowned research hospitals to accelerate development and industrialization of next-generation genomic medicine. Inspired by recent advancements in cell and gene therapy, Landmark Bio was established to remove barriers in drug development, create accessible capability, expertise, and solutions, and offer a collaboration platform to advance manufacturing...
Podimetrics is a virtual care management company dedicated to preventing costly and deadly diabetic amputations. We provide high-risk patients our FDA-cleared SmartMat™ through partnerships with payers and at-risk providers, including the Veterans Health Administration. After placing their feet on the mat for just 20 seconds a day, patients’ data are automatically sent to our care management team, which helps address...
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and...
